Stents showed no clear difference in pancreatic fistulas compared with no stents (low certainty).
Stents showed no clear difference in in‐hospital mortality compared with no stents (moderate certainty).
Stents showed no clear difference in reoperation compared with no stents (moderate certainty).
Stents showed no clear difference in delayed gastric emptying compared with no stents (moderate certainty).
Stents showed no clear difference in intra‐abdominal abscess compared with no stents (low certainty).
Stents showed no clear difference in wound infection compared with no stents (moderate certainty).
Internal stents showed no clear difference in reoperation compared with external stents (low certainty).
Internal stents showed no clear difference in delayed gastric emptying compared with external stents (low certainty).
Internal stents showed no clear difference in pancreatitis compared with external stents (low certainty).
Internal stents showed no clear difference in intra‐abdominal abscess compared with external stents (low certainty).
Internal stents showed no clear difference in wound infection compared with external stents (moderate certainty).
Internal stents showed no clear difference in pancreatic fistulas compared with external stents (low certainty).
Internal stents showed no clear difference in in‐hospital mortality compared with external stents (low certainty).
Drug‐eluting stents showed no clear difference in all‐cause mortality at maximum compared with bare‐metal stents (low certainty).
Drug‐eluting stents may leads to lower serious adverse events at maximum compared with bare‐metal stents (low certainty).
It is very uncertain whether drug‐eluting stents changes major cardiovascular events at maximum compared with bare‐metal stents (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether drug‐eluting stents changes cardiovascular mortality at maximum compared with bare‐metal stents (very low certainty).